Close Menu

NEW YORK – Preventive genomics medicine company Veritas Intercontinental said on Thursday that it has completed a €5 million ($5.8 million) Series B financing round.

The round was led by Charme Capital Partners and Amadeus Capital Partners, who have invested in the Veritas Genetics spinoff firm since it was founded in 2018. They were joined in the Series B round by Stemar Capital Partners and entrepreneur Graham Snudden.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.